The Bridge program, which began on July 1, 2026, allows some Medicare beneficiaries to access obesity drugs for a monthly fee of $50. Drugstore chains CVS and Walgreens reported that they have each filled approximately 100,000 prescriptions under this program.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Medicare's $50 obesity drug program sees early adoption
The Bridge program launched on July 1, 2026, enabling certain Medicare beneficiaries to obtain obesity medications for $50 per month. CVS and Walgreens have each reported filling around 100,000 prescriptions since the program's inception.
Companies
CVS
Walgreens
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Drugstores say Medicare's $50 obesity drug program is catching on
Neutral Headline
Medicare's $50 obesity drug program sees early adoption